Literature DB >> 28181241

Interplay between miRNAs and human diseases.

Prosenjit Paul1, Anindya Chakraborty1, Debasree Sarkar1, Malobika Langthasa1, Musfhia Rahman1, Minakshi Bari1, Rk Sanamacha Singha1, Arup Kumar Malakar1, Supriyo Chakraborty1.   

Abstract

MicroRNAs (miRNAs) are endogenous, non-coding RNAs, which have evoked a great deal of interest due to their importance in many aspects of homeostasis and diseases. MicroRNAs are stable and are essential components of gene regulatory networks. They play a crucial role in healthy individuals and their dysregulations have also been implicated in a wide range of diseases, including diabetes, cardiovascular disease, kidney disease, and cancer. This review summarized the current understanding of interactions between miRNAs and different diseases and their role in disease diagnosis and therapy.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; homeostasis; insulin; kidney disease; miRNA

Mesh:

Substances:

Year:  2017        PMID: 28181241     DOI: 10.1002/jcp.25854

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  119 in total

1.  Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1.

Authors:  Shuyue Wang; Chen Liang; Huihan Ai; Meiting Yang; Jingwen Yi; Lei Liu; Zhenbo Song; Yongli Bao; Yuxin Li; Luguo Sun; Huiying Zhao
Journal:  Dig Dis Sci       Date:  2019-01-09       Impact factor: 3.199

2.  The human box C/D snoRNA U3 is a miRNA source and miR-U3 regulates expression of sortin nexin 27.

Authors:  Nicolas Lemus-Diaz; Rafael Rinaldi Ferreira; Katherine E Bohnsack; Jens Gruber; Markus T Bohnsack
Journal:  Nucleic Acids Res       Date:  2020-08-20       Impact factor: 16.971

Review 3.  Physical Exercise and Epigenetic Modifications in Skeletal Muscle.

Authors:  Manuel Widmann; Andreas M Nieß; Barbara Munz
Journal:  Sports Med       Date:  2019-04       Impact factor: 11.136

4.  Micro-RNAs involved in cellular proliferation have altered expression profiles in granulosa of young women with diminished ovarian reserve.

Authors:  Irene Woo; Lane K Christenson; Sumedha Gunewardena; Sue Ann Ingles; Semara Thomas; Ali Ahmady; Karine Chung; Kristin Bendikson; Richard Paulson; Lynda K McGinnis
Journal:  J Assist Reprod Genet       Date:  2018-07-09       Impact factor: 3.412

Review 5.  Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism.

Authors:  Tomas Smutny; Lucie Hyrsova; Albert Braeuning; Magnus Ingelman-Sundberg; Petr Pavek
Journal:  Arch Toxicol       Date:  2020-11-09       Impact factor: 5.153

Review 6.  Significance of Mitochondrial Protein Post-translational Modifications in Pathophysiology of Brain Injury.

Authors:  Nina Klimova; Aaron Long; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2017-09-21       Impact factor: 6.829

7.  LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.

Authors:  Zoya Najafi; Mohammadreza Sharifi; Gholamreza Javadi
Journal:  J Gastrointest Cancer       Date:  2020-03

8.  MicroRNA-208a: a Good Diagnostic Marker and a Predictor of no-Reflow in STEMI Patients Undergoing Primary Percutaneuos Coronary Intervention.

Authors:  Aboubakr Mohamed Salama; Wael Ali Khalil; Manar Al-Zaky; Somia Hassan Abdallah; Nader Talaat Kandil; Ahmed Abdelsabour; Ahmed Mohammed Shaker; Mesbah Taha Hasanein; Giovanni Battista Luciani; Hassan M E Azzazy
Journal:  J Cardiovasc Transl Res       Date:  2020-05-26       Impact factor: 4.132

Review 9.  miRNA Targeting: Growing beyond the Seed.

Authors:  Laura B Chipman; Amy E Pasquinelli
Journal:  Trends Genet       Date:  2019-01-09       Impact factor: 11.639

10.  Gld2 activity is regulated by phosphorylation in the N-terminal domain.

Authors:  Christina Z Chung; Nileeka Balasuriya; Emad Manni; Xuguang Liu; Shawn Shun-Cheng Li; Patrick O'Donoghue; Ilka U Heinemann
Journal:  RNA Biol       Date:  2019-05-05       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.